Caitlin Clark may not be playing a lot of basketball this offseason, but she continues to make headlines with her activities away from the WNBA. The Indiana Fever star, who played just 13 games last ...

Despite the NFL's attempts to take over every holiday, the NBA on Christmas Day remains the most important sport today. However, Nike actually led with a WNBA star in the first of many commercials ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Alex Clark, a former radio host, now leads the health and wellness podcast "Culture Apothecary," powered by Turning Point USA. Clark joined Turning Point USA in 2019 after pitching a show idea to ...

Fever star Caitlin Clark has returned to the court after a season limited by multiple injuries. Clark is participating in a USA Basketball training camp in North Carolina. She is one of 17 players at ...

Indiana Fever star Caitlin Clark is known by many WNBA fans for what she does on the court. The No. 1 overall draft pick captured the attention of the league in 2024 by breaking records, leading the ...

'It Happened One Night' star Clark Gable’s marriages were marked by tragedy Nicole Briese is a contributing writer at PEOPLE. She has been working at PEOPLE since 2022. Her work has previously ...

Caitlin Clark is a prominent WNBA player for the Indiana Fever. Clark recovered from injury, played in the pro-am event before THE ANNIKA. “Had a blast running it back for year 2,” Clark shared on ...

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, Tylenol, is in the crosshairs of the White House. Kimberly-Clark said it would ...

Kimberly-Clark will buy Kenvue for $48.7 billion. A merged Kimberly-Clark-Kenvue could have $32 billion in annual sales and profits as high as $5.5 billion. At Kimberly-Clark's current $40 billion ...

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining the Huggies manufacturer with the owner of Aveeno and Band-Aid. Kenvue ...